AcceleraME, Inc — SEC Form D Filing

AcceleraME, Inc filed an SEC Form D on August 3, 2026, reporting $1.82M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 3, 2026
Amount reported
$1.82M
Industry
Medical Devices
Website
http://www.accelera.us/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many people struggle with maintaining balance, experience unsteadiness, or find everyday tasks like reaching, grasping, and walking challenging, often due to age-related changes or other movement difficulties.

Solution

Accelera offers a wearable balance device that uses randomized vibration patterns (stochastic resonance) to provide gentle, patterned sensory input, which helps reinforce sensory connection, improve proprioception, and support postural stability and movement awareness.

Verdict

Investors backed this because the core mechanism of stochastic resonance for sensory enhancement had existing scientific validation, not because the company had proven commercial traction in a consumer medical device market. The implicit bet was on translating a known biophysical principle into a marketable product for a broad demographic experiencing age-related balance decline. Upside was constrained by the consumer adoption curve for discreet, non-invasive health tech and the potential for skepticism around non-pharmaceutical interventions.

Source: SEC EDGAR Form D filing